Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Egyptian Journal of Medical Human Genetics [The]. 2018; 19 (2): 77-81
in English | IMEMR | ID: emr-192873

ABSTRACT

Background: Genetic and environmental factors are known to be risk factors in development of neovascular age-related macular degeneration [nAMD]. Genetic factors such as polymorphisms in the complement component pathway genes might play a role in pathogenesis of nAMD and has been studied in various populations excluding Malaysia


Aim of the study: To determine the association of the R102G polymorphism of the complement component [C3] gene in nAMD subjects


Patients and methods: A total of 301 Malaysian subjects [149 case and 152 controls] were recruited and genotyped for the R102G [rs2230199] variant of the C3 gene. Genotyping was conducted using the PCRRFLP method and association analysis was conducted using appropriate statistical tests


Results: From our findings, no significant association was observed in the allele distribution of C3 R102G between nAMD and controls [OR = 1.42, 95% CI = 0.77-2.62, P = 0.268]. A further analysis that compared three genetic models [dominant, recessive and co-dominant] also recorded no significant difference [P > 0.05]. These findings could be due to the low frequency of the GG variant in the case [4.7%] and control [1.3%] groups, compared to the normal variant CC, which is present in 91.3% of case and 92.8% of control alleles


Conclusion: The present study showed no evidence of association between C3 R102G polymorphism and nAMD in Malaysian subjects

2.
Annals of the Academy of Medicine, Singapore ; : 530-534, 2015.
Article in English | WPRIM | ID: wpr-309483

ABSTRACT

<p><b>INTRODUCTION</b>Treatment of acute lymphoblastic leukaemia (ALL) using intensive chemotherapy has resulted in high cure rates but also substantial morbidity. Infective complications represent a significant proportion of treatment-related toxicity. The objective of this study was to describe the microbiological aetiology and clinical outcome of episodes of chemotherapy-induced febrile neutropaenia in a cohort of children treated for ALL at our institution.</p><p><b>MATERIALS AND METHODS</b>Patients with ALL were treated with either the HKSGALL93 or the Malaysia-Singapore (Ma-Spore) 2003 chemotherapy protocols. The records of 197 patients who completed the intensive phase of treatment, defined as the period of treatment from induction, central nervous system (CNS)-directed therapy to reinduction from June 2000 to January 2010 were retrospectively reviewed.</p><p><b>RESULTS</b>There were a total of 587 episodes of febrile neutropaenia in 197 patients, translating to an overall rate of 2.98 episodes per patient. A causative pathogen was isolated in 22.7% of episodes. An equal proportion of Gram-positive bacteria (36.4%) and Gram-negative bacteria (36.4%) were most frequently isolated followed by viral pathogens (17.4%), fungal pathogens (8.4%) and other bacteria (1.2%). Fungal organisms accounted for a higher proportion of clinically severe episodes of febrile neutropaenia requiring admission to the high-dependency or intensive care unit (23.1%). The overall mortality rate from all episodes was 1.5%.</p><p><b>CONCLUSION</b>Febrile neutropaenia continues to be of concern in ALL patients undergoing intensive chemotherapy. The majority of episodes will not have an identifiable causative organism. Gram-positive bacteria and Gram-negative bacteria were the most common causative pathogens identified. With appropriate antimicrobial therapy and supportive management, the overall risk of mortality from febrile neutropaenia is extremely low.</p>


Subject(s)
Child , Humans , Candidiasis , Epidemiology , Chemotherapy-Induced Febrile Neutropenia , Epidemiology , Microbiology , Cohort Studies , Escherichia coli Infections , Epidemiology , Gram-Negative Bacterial Infections , Epidemiology , Gram-Positive Bacterial Infections , Epidemiology , Influenza, Human , Epidemiology , Klebsiella Infections , Epidemiology , Mycoses , Epidemiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma , Drug Therapy , Pseudomonas Infections , Epidemiology , Retrospective Studies , Singapore , Epidemiology , Staphylococcal Infections , Epidemiology , Virus Diseases , Epidemiology
3.
Annals of the Academy of Medicine, Singapore ; : 170-175, 2012.
Article in English | WPRIM | ID: wpr-299665

ABSTRACT

<p><b>INTRODUCTION</b>The care of children with cancer creates emotional and financial hardships for their families. There is a lack of information on the impact of childhood cancer on the family as a whole in Singapore. Thus, we set out to assess the financial impact as well as its psychosocial impact in our local context.</p><p><b>MATERIALS AND METHODS</b>All patients diagnosed and treated for cancer at the Departments of Paediatrics, KK Women's and Children's Hospital and National University Hospital, Singapore were eligible for this study. Families of these patients completed 2 self-administered questionnaires: (i) About-you and your-family and (ii) the Impact-On-Family scale. For the latter, the total score was obtained by the summation of all scores, where high scores correlated to high impact.</p><p><b>RESULTS</b>Seventy-nine parents were enrolled during the study period from October 2008 to February 2009. Being of Malay/Indian origin was associated with a high overall family burden. On the other hand, being of Malay/Indian origin was also associated with most successful at mastery when a child was diagnosed with cancer (P = 0.001). In addition, when compared to caregivers who remained employed, those who were asked to quit their job, experienced a higher Financial Burden (P = 0.03), a high Familial/Social Burden (P = 0.05) and a high Personal Strain (P = 0.03).</p><p><b>CONCLUSION</b>Childhood cancer impacted family life in Singapore at many levels. In particular, the factors involved are various cultural discourses; employment status of caregivers; and those whose leave/pay are affected.</p>


Subject(s)
Adult , Female , Humans , Male , Caregivers , Psychology , Cost of Illness , Employment , Economics , Family , Psychology , Family Health , Neoplasms , Economics , Psychology , Singapore , Surveys and Questionnaires
4.
Annals of the Academy of Medicine, Singapore ; : 314-318, 2007.
Article in English | WPRIM | ID: wpr-250824

ABSTRACT

<p><b>INTRODUCTION</b>Medulloblastoma/primitive neuroectodermal tumour is the most common type of malignant brain tumour in children. Long-term survival rates have improved over the years with a combination of surgical, radiotherapeutic and chemotherapeutic treatment modalities in the developed world. This paper aims to analyse the epidemiology and outcome of medulloblastoma in Singapore and compare our results with those reported in the literature.</p><p><b>MATERIALS AND METHODS</b>A 9-year retrospective study was done using data reported to the Singapore Children's Cancer Registry from June 1997 to June 2005. Only 39 children up to the age of 15 years diagnosed histologically with medulloblastoma or primitive neuroectodermal tumour arising from the cerebellum were included in the study. Follow-up data were collected up to June 2006 and analysed using SPSS v 13.0 software.</p><p><b>RESULTS</b>Medulloblastoma/primitive neuroectodermal tumour was the most common type of brain tumour, accounting for 40.7% of all brain tumours diagnosed in children in Singapore. The 5-year event-free survival rate was 44.5%, while the 5- year overall survival rate was 51.5%. Nearly half (41%) of our patients had spinal metastasis at presentation and this was associated with a worse event-free survival (6.3% vs 71.9%, P = 0). Children under 36 months of age had a significantly poorer overall survival (28.8% vs 52.2%, P = 0.041).</p><p><b>CONCLUSIONS</b>The outcome of medulloblastoma in Singapore was inferior to reported figures in the literature. We need to close identified gaps in care, like standardising assessment and treatment protocols, in order to improve our results. Research into molecular and genetic characteristics may also throw light on whether the disease is inherently more aggressive in our population.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Disease Management , Medulloblastoma , Epidemiology , Therapeutics , Outcome Assessment, Health Care , Registries , Retrospective Studies , Singapore , Epidemiology , Survival Rate
5.
Annals of the Academy of Medicine, Singapore ; : 753-758, 2006.
Article in English | WPRIM | ID: wpr-275272

ABSTRACT

<p><b>INTRODUCTION</b>Complementary and alternative medicine (CAM) is garnering increasing interest and acceptance among the general population. Although usage is thought to be widespread among paediatric cancer patients, local studies have not been done. We aimed to investigate the prevalence and predictors of CAM usage in paediatric cancer patients in a single institution.</p><p><b>MATERIALS AND METHODS</b>Parents of 73 paediatric cancer patients treated at KK Women's & Children's Hospital completed an interviewer-administered questionnaire. Data about the types of CAM therapies used, motivations for use, adverse effects, costs and discussion of usage with the patient's physician were obtained. General perceptions towards CAM and conventional medicine were explored. A subsequent telephone survey enquired about spirituality, benefits of CAM use and overall satisfaction with the therapies.</p><p><b>RESULTS</b>Two-thirds of patients used at least 1 CAM treatment, mainly as supportive adjuncts to conventional cancer treatment. Dietary changes, health supplements, herbal tea and bird's nest were the most common therapies used. Few patients (8.1%) consulted a CAM practitioner. Positive predictors of CAM usage included being of Chinese race, the practice of Buddhism or Taoism, the use of CAM prior to diagnosis, perception of CAM effectiveness and dissatisfaction with conventional treatment. Significantly, 55.1% of the parents had not discussed their CAM usage with their child's physician.</p><p><b>CONCLUSIONS</b>A substantial proportion of paediatric cancer patients utilises CAM therapies, often without their physician's knowledge. Healthcare providers need to remain cognisant of the potential implications of CAM usage in order to proactively counsel patients. This would ensure that conventional therapy remains uncompromised.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Medical Oncology , Methods , Medicine, Chinese Traditional , Neoplasms , Epidemiology , Therapeutics , Patient Satisfaction , Pediatrics , Methods , Prevalence , Singapore , Epidemiology
6.
Annals of the Academy of Medicine, Singapore ; : 897-900, 2006.
Article in English | WPRIM | ID: wpr-275246

ABSTRACT

<p><b>INTRODUCTION</b>Stenotrophomonas maltophilia is an aerobic gram-negative bacillus that is a frequent coloniser of fluids used in the hospital setting. It causes infection in immunosuppressed hosts, especially those who are neutropaenic, on chemotherapy and broad spectrum antibiotics. Skin and soft tissue manifestations of Stenotrophomonas maltophilia infection are becoming an increasingly recognised entity; the clinical spectrum ranges from mucocutaneous, skin to soft tissue infections.</p><p><b>MATERIALS AND METHODS</b>We present a case of an 8-year-old girl with acute myeloid leukaemia who developed metastatic skin lesions secondary to Stenotrophomonas maltophilia bacteraemia. The authors reviewed a total of 24 reported cases of mucocutaneous, skin and soft tissue infections by Stenotrophomonas maltophilia. The presentations include metastatic cellulitis, primary cellulitis and infected mucocutaneous ulcers.</p><p><b>RESULTS</b>This is the first locally reported case of metastatic nodular skin lesions caused by Stenotrophomonas maltophilia bacteraemia. This is also the first reported paediatric case of embolic skin lesions caused by Stenotrophomonas maltophilia. Of the 6 cases of Stenotrophomonas maltophilia bacteraemia seen in the paediatric oncology patients from year 2000 to 2004 at our hospital, only 1 case developed metastatic skin lesions.</p><p><b>CONCLUSION</b>Stenotrophomonas maltophilia skin infection should be included into the list of differential diagnoses for metastatic skin lesions in neutropaenic patients, especially with an underlying haematologic malignancy who has received recent chemotherapy and broad spectrum antibiotics. Haematologic malignancy, transplantation, neutropaenic, immunosuppressive therapy and a high severity of illness score were important prognostic factors.</p>


Subject(s)
Child , Female , Humans , Acute Disease , Anti-Infective Agents , Therapeutic Uses , Bacteremia , Epidemiology , Microbiology , Cellulitis , Epidemiology , Microbiology , Comorbidity , Gram-Negative Bacterial Infections , Leukemia, Myeloid , Epidemiology , Neutropenia , Epidemiology , Prognosis , Skin Diseases, Bacterial , Epidemiology , Stenotrophomonas maltophilia , Trimethoprim, Sulfamethoxazole Drug Combination , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL